Vilas Satishchandran

930 total citations
19 papers, 747 citations indexed

About

Vilas Satishchandran is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Surgery. According to data from OpenAlex, Vilas Satishchandran has authored 19 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Medicine, 6 papers in Applied Microbiology and Biotechnology and 4 papers in Surgery. Recurrent topics in Vilas Satishchandran's work include Antibiotic Resistance in Bacteria (7 papers), Antibiotic Use and Resistance (6 papers) and Cardiac and Coronary Surgery Techniques (3 papers). Vilas Satishchandran is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Antibiotic Use and Resistance (6 papers) and Cardiac and Coronary Surgery Techniques (3 papers). Vilas Satishchandran collaborates with scholars based in United States, Canada and Spain. Vilas Satishchandran's co-authors include Allan L. Truant, Hedy Teppler, Joseph W. Chow, Mark J. DiNubile, Charlotte M. Harvey, Toby K. Eisenstein, Joseph J. Meissler, Martin W. Adler, Mary E. Hilburger and Thomas J. Rogers and has published in prestigious journals such as Clinical Infectious Diseases, Annals of Surgery and The American Journal of Medicine.

In The Last Decade

Vilas Satishchandran

19 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vilas Satishchandran United States 13 254 226 220 193 120 19 747
Sandrine Lefeuvre France 17 190 0.7× 494 2.2× 362 1.6× 131 0.7× 93 0.8× 36 928
Yazdan Mirzanejad Canada 13 107 0.4× 174 0.8× 356 1.6× 102 0.5× 92 0.8× 22 753
A. García-Curiel Spain 12 550 2.2× 235 1.0× 331 1.5× 135 0.7× 174 1.4× 16 1.1k
Federica Pavan Italy 14 120 0.5× 419 1.9× 167 0.8× 64 0.3× 67 0.6× 23 674
T. Aldabó-Pallás Spain 7 194 0.8× 107 0.5× 343 1.6× 124 0.6× 34 0.3× 11 625
Sean Nguyen United States 14 105 0.4× 124 0.5× 176 0.8× 90 0.5× 36 0.3× 32 481
William K. Lau United States 10 159 0.6× 272 1.2× 250 1.1× 45 0.2× 74 0.6× 12 1.3k
Virginia Pomar Spain 20 315 1.2× 173 0.8× 382 1.7× 140 0.7× 114 0.9× 43 1.2k
Leonidas Gregorakos Greece 10 244 1.0× 165 0.7× 199 0.9× 59 0.3× 33 0.3× 15 520
Luigi Celani Italy 11 352 1.4× 200 0.9× 194 0.9× 125 0.6× 22 0.2× 25 802

Countries citing papers authored by Vilas Satishchandran

Since Specialization
Citations

This map shows the geographic impact of Vilas Satishchandran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vilas Satishchandran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vilas Satishchandran more than expected).

Fields of papers citing papers by Vilas Satishchandran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vilas Satishchandran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vilas Satishchandran. The network helps show where Vilas Satishchandran may publish in the future.

Co-authorship network of co-authors of Vilas Satishchandran

This figure shows the co-authorship network connecting the top 25 collaborators of Vilas Satishchandran. A scholar is included among the top collaborators of Vilas Satishchandran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vilas Satishchandran. Vilas Satishchandran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Perrault, Louis P., Michel Carrier, Pierre Voisine, et al.. (2019). Sequential multidetector computed tomography assessments after venous graft treatment solution in coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery. 161(1). 96–106.e2. 18 indexed citations
2.
Caliskan, Etem, Sigrid Sandner, Martín Misfeld, et al.. (2019). A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry. Journal of Cardiothoracic Surgery. 14(1). 174–174. 12 indexed citations
3.
Ali, Walid Ben, Pierre Voisine, Peter Skov Olsen, et al.. (2018). DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial. Open Heart. 5(1). e000780–e000780. 11 indexed citations
4.
5.
6.
Paterson, David L., Flávia Rossi, Fernando Baquero, et al.. (2005). In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). Journal of Antimicrobial Chemotherapy. 55(6). 965–973. 157 indexed citations
7.
DiNubile, Mark J., Joseph W. Chow, Vilas Satishchandran, et al.. (2005). Acquisition of Resistant Bowel Flora during a Double-Blind Randomized Clinical Trial of Ertapenem versus Piperacillin-Tazobactam Therapy for Intraabdominal Infections. Antimicrobial Agents and Chemotherapy. 49(8). 3217–3221. 41 indexed citations
8.
Solomkin, Joseph S., Albert E. Yellin, Ori D. Rotstein, et al.. (2003). . Annals of Surgery. 237(2). 235–245. 37 indexed citations
9.
Solomkin, Joseph S., Albert E. Yellin, Ori D. Rotstein, et al.. (2003). Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections. Annals of Surgery. 237(2). 235–245. 148 indexed citations
10.
Truant, Allan L., et al.. (1998). Methylobacterium bacteremia in AIDS. Clinical Microbiology and Infection. 4(2). 112–113. 8 indexed citations
11.
Truant, Allan L., et al.. (1998). MethylobacteriumSpecies: An Increasingly Important Opportunistic Pathogen. Laboratory Medicine. 29(11). 704–710. 18 indexed citations
12.
Hilburger, Mary E., Martin W. Adler, Allan L. Truant, et al.. (1997). Morphine Induces Sepsis in Mice. The Journal of Infectious Diseases. 176(1). 183–188. 131 indexed citations
13.
14.
Suh, Byungse, et al.. (1995). In vitro activity of β-lactamase inhibitors against clinical isolates of Acinetobacter species. Diagnostic Microbiology and Infectious Disease. 21(2). 111–114. 18 indexed citations
15.
Axelrod, Peter, et al.. (1994). Investigation of a Pseudo-Outbreak of Orthopedic Infections Caused by Pseudomonas aeruginosa. Infection Control and Hospital Epidemiology. 15(10). 652–657. 10 indexed citations
16.
Axelrod, Peter, et al.. (1994). Investigation of a Pseudo-Outbreak of Orthopedic Infections Caused by Pseudomonas aeruginosa. Infection Control and Hospital Epidemiology. 15(10). 652–657. 5 indexed citations
17.
Jones, Ruth S., Thomas Fekete, Allan L. Truant, & Vilas Satishchandran. (1994). Persistent Baeteremia Due to Tsukamurella paurometabolum in a Patient Undergoing Hemodialysis: Case Report and Review. Clinical Infectious Diseases. 18(5). 830–831. 23 indexed citations
18.
Truant, Allan L. & Vilas Satishchandran. (1993). Comparison of Streptex versus PathoDx for group D typing of vancomycin-resistant Enterococcus. Diagnostic Microbiology and Infectious Disease. 16(1). 89–91. 1 indexed citations
19.
Wadsworth, Sandra J., et al.. (1992). Development of new antibiotic resistance in methicillin-resistant but not methicillin-susceptible Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 30(6). 821–826. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandrine Lefeuvre Breakdown of academic impact, for papers by Yazdan Mirzanejad Breakdown of academic impact, for papers by A. García-Curiel Breakdown of academic impact, for papers by Federica Pavan Breakdown of academic impact, for papers by T. Aldabó-Pallás Breakdown of academic impact, for papers by Sean Nguyen Breakdown of academic impact, for papers by William K. Lau Breakdown of academic impact, for papers by Virginia Pomar Breakdown of academic impact, for papers by Leonidas Gregorakos Breakdown of academic impact, for papers by Luigi Celani
Rankless by CCL
2026